» Articles » PMID: 32059683

Characteristics and Treatment Results of Recurrence in Adult-type Granulosa Cell Tumor of Ovary

Overview
Journal J Ovarian Res
Publisher Biomed Central
Date 2020 Feb 16
PMID 32059683
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to explore the clinicopathological characteristics of recurrent adult-type granulosa cell tumor of the ovary (AGCOT) and evaluated the treatment results to define the prognostic parameters for survival after recurrence.

Results: A retrospective review of 40 patients with recurrent AGCOT, who were treated in the Cancer Hospital at the Chinese Academy of Medical Sciences from 2000 to 2015 was conducted. The impact of clinical and pathological characteristics, progression-free survival (PFS), and post-recurrence therapeutic approaches on prognosis were analyzed. Among the 40 recurrent patients, there were 10 cases where the relapse was uncontrolled, 24 cases had second relapses, and 6 cases without further relapses at the time of our follow-up. The median PFS was 61 months (range, 7-408 months), and the median time interval between the first and the second relapses (R-PFS) was 25 months (range, 0-94 months). The median time interval between the first relapse and death (R-OS) was 90 months (range, 2-216 months). PFS ≥ 61 months (P = 0.004) and post-recurrence therapeutic approach (P < 0.001) were independent risk factors for repeated recurrences. The age at recurrence (P = 0.031) and post-recurrence therapeutic approach (P = 0.001) were independent risk factors for death after recurrence.

Conclusion: Among patients with recurrent AGCOT, those with long PFS had good prognoses. Maximal cytoreductive effort should be made after recurrence. Complete resection and postoperative adjuvant chemotherapy may improve the prognosis of patients with recurrent AGCOT.

Citing Articles

The Surgical Odyssey: A Case Report on Rare Isolated Abdominal Wall Recurrence in an Adult Ovarian Granulosa Cell Tumor.

Garg M, Ahlawat R, Mathew J, Bhati P, Thomas S, Samuel S Cureus. 2024; 16(11):e74708.

PMID: 39735028 PMC: 11682846. DOI: 10.7759/cureus.74708.


Management challenges of ovarian adult-type granulosa cell tumors at a tertiary facility in resource-limited setting: A case series of three patients and review of the current literature.

Lugata J, Makower L, Rapheal A, Maro E, Mremi A, Mchome B Int J Surg Case Rep. 2024; 126():110729.

PMID: 39667123 PMC: 11697405. DOI: 10.1016/j.ijscr.2024.110729.


Clinical features and survival rate of patients with ovarian granulosa cell tumor in Iran; a 10-year retrospective study.

Mousavi A, Eshraghi N, Akhavan S, Sheikhhasani S, Zamani N, Valian Z BMC Cancer. 2024; 24(1):1318.

PMID: 39455974 PMC: 11515796. DOI: 10.1186/s12885-024-13069-w.


Risk Factors and Clinical Outcomes of Recurrence in Adult Ovarian Granulosa Cell Tumors.

Golmohammadi Tavallaee M, Hasanzadeh Mofrad M, Yousefi Z, Mottaghi M, Homaei Shandiz F, Davachi B Cancer Rep (Hoboken). 2024; 7(10):e70036.

PMID: 39453686 PMC: 11505513. DOI: 10.1002/cnr2.70036.


Story of 20 Years of Triumph: A Case Report of Two Patients With Stage IV Granulosa Cell Tumor of the Ovary.

Bin Naeem S, Imran M, Abbas M, Majeed M, Jamil M, Samreen M Cureus. 2024; 16(4):e57615.

PMID: 38707031 PMC: 11069410. DOI: 10.7759/cureus.57615.


References
1.
Sun H, Lin H, Jao M, Wang K, Liou W, Hung Y . A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors. Gynecol Oncol. 2011; 124(2):244-9. DOI: 10.1016/j.ygyno.2011.10.015. View

2.
Young R . Ovarian sex cord-stromal tumours and their mimics. Pathology. 2017; 50(1):5-15. DOI: 10.1016/j.pathol.2017.09.007. View

3.
Meisel J, Hyman D, Jotwani A, Zhou Q, Abu-Rustum N, Iasonos A . The role of systemic chemotherapy in the management of granulosa cell tumors. Gynecol Oncol. 2014; 136(3):505-11. PMC: 4532352. DOI: 10.1016/j.ygyno.2014.12.026. View

4.
Dridi M, Chraiet N, Batti R, Ayadi M, Mokrani A, Meddeb K . Granulosa Cell Tumor of the Ovary: A Retrospective Study of 31 Cases and a Review of the Literature. Int J Surg Oncol. 2018; 2018:4547892. PMC: 5896205. DOI: 10.1155/2018/4547892. View

5.
Bryk S, Pukkala E, Martinsen J, Unkila-Kallio L, Tryggvadottir L, Sparen P . Incidence and occupational variation of ovarian granulosa cell tumours in Finland, Iceland, Norway and Sweden during 1953-2012: a longitudinal cohort study. BJOG. 2016; 124(1):143-149. DOI: 10.1111/1471-0528.13949. View